The Medicines Company announced that it has appointed Alexander J. Denner, Ph.D. to its board of directors. Dr. Denner will serve as a Class III director with a term expiring at the company's 2018 Annual Meeting of Stockholders. He will also serve on the Company's Nominating and Corporate Governance Committee.

With the appointment of Dr. Denner, which was effective on February 2, 2016, the Company's Board of Directors is comprised of 11 directors, ten of whom are independent. Dr. Denner is the chief investment officer of Sarissa Capital Management LP, which he founded in 2012. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital.

Prior to that, he served as a portfolio manager at Viking Global Investors and Morgan Stanley Investment Management.